The historical rank and industry rank for Beximco Pharmaceuticals's Net Margin % or its related term are showing as below:
BXMPY'
s Net Margin % Range Over the Past 10 Years
Min: 11.75 Med: 14.02 Max: 17.39
Current: 13.71
BXMPY's Net Margin % is not ranked
in the Drug Manufacturers industry.
Industry Median: 5.56
vs BXMPY: 13.71
Beximco Pharmaceuticals (OTCPK:BXMPY) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Beximco Pharmaceuticals Net Margin % Related Terms
Beximco Pharmaceuticals Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Beximco Pharmaceuticals's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beximco Pharmaceuticals Net Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Beximco Pharmaceuticals's Net Margin % distribution charts can be found below:
* The bar in red indicates where Beximco Pharmaceuticals's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beximco Pharmaceuticals (BXMPY) has a Net Margin % of 14.88% as of Dec. 2024. Net margin is the ratio of total net income to net sales. View historical data on Beximco Pharmaceuticals and its competitors. This is near median its historical median of 14.02. Over the past decade, Beximco Pharmaceuticals' Net Margin % has ranged from 11.75 to 17.39.
Is Beximco Pharmaceuticals' Net Margin % too high?
Beximco Pharmaceuticals' current Net Margin % of 14.88% is near median its 10-year median of 14.02. Over the past 10 years, this metric has ranged from a low of 11.75 to a high of 17.39. The Drug Manufacturers industry median Net Margin % is 5.56. Beximco Pharmaceuticals' value of 14.88% is 167.6% above this industry median. Overall, Beximco Pharmaceuticals has a GF Score™ of 97/100, reflecting its overall financial health beyond just this single metric.
How does Beximco Pharmaceuticals' Net Margin % compare to ZTS and UTHR?
Beximco Pharmaceuticals' Net Margin % of 14.88% can be compared against companies in the Drug Manufacturers industry. The industry median Net Margin % is 5.56. Beximco Pharmaceuticals' value of 14.88% is 167.6% above this benchmark. Historically, Beximco Pharmaceuticals' own Net Margin % has ranged from 11.75 to 17.39 over the past decade. While the company's 10-year median is 14.02 vs. the industry median of 5.56, Beximco Pharmaceuticals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.56, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Beximco Pharmaceuticals's current Net Margin % of 14.88% is 167.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Beximco Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beximco Pharmaceuticals's current Net Margin % is 14.88%, which is near median its own 10-year median of 14.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beximco Pharmaceuticals stock overvalued right now?
Beximco Pharmaceuticals (BXMPY) has a current Net Margin % of 14.88%. The current Net Margin % is 14.88%, which is near median its 10-year median of 14.02 and 167.6% above the Drug Manufacturers industry median of 5.56. Beximco Pharmaceuticals' overall GF Score™ is 97/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Beximco Pharmaceuticals (BXMPY), the current Net Margin % is 14.88% as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Beximco Pharmaceuticals PLC is engaged in manufacturing and marketing a wide range of generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and Active Pharmaceutical Ingredients. It manufactures various pharmaceutical products including oral contraceptives, hormones, steroids, anti-histamine, anti-fibrinolytic, cardiac, musculoskeletal, respiratory, vitamin & mineral supplements, women's health products, and others. The products of the company are sold in domestic and international markets. Key revenue accrues from domestic sales.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BXMPY has been successfully added to your 